Greenwich LifeSciences (GLSI) Institutional Ownership $12.49 +0.31 (+2.55%) Closing price 04:00 PM EasternExtended Trading$12.49 0.00 (0.00%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Greenwich LifeSciences (NASDAQ:GLSI)CurrentInstitutional OwnershipPercentage4.16%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$1.56MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$138.78K Get GLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLSI Institutional Buying and Selling by Quarter Greenwich LifeSciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025 Police & Firemen s Retirement System of New Jersey2,768$25K0.0%N/A0.021% 8/8/2025 Geode Capital Management LLC138,982$1.26M0.0%+1.4%1.040% 5/29/2025Rhumbline Advisers9,673$92K0.0%+48.7%0.072% 5/28/2025 Strs Ohio18,600$177K0.0%N/A0.139% 5/13/2025HighTower Advisors LLC15,407$147K0.0%N/A0.116% 5/9/2025Charles Schwab Investment Management Inc.19,007$181K0.0%+15.5%0.143% 4/8/2025Rhumbline Advisers9,673$92K0.0%+48.7%0.074% 4/7/2025 GAMMA Investing LLC1,202$126K0.0%N/A0.009% 2/17/2025Bank of America Corp DE7,262$82K0.0%+22.3%0.055% 2/14/2025Northern Trust Corp87,423$982K0.0%+17.3%0.665% Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025Barclays PLC9,648$108K0.0%+12.7%0.073% 2/13/2025Renaissance Technologies LLC22,700$255K0.0%-30.2%0.173% 2/13/2025Wells Fargo & Company MN2,847$32K0.0%+54.8%0.022% 2/12/2025Brown Brothers Harriman & Co.4,000$45K0.0%N/A0.030% 2/12/2025JPMorgan Chase & Co.7,061$79K0.0%+172.0%0.054% 12/10/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/19/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/16/2024 Geode Capital Management LLC133,550$1.92M0.0%+4.6%1.016% 11/15/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/15/2024State Street Corp71,408$1.03M0.0%+4.4%0.543% 11/15/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/12/2024Charles Schwab Investment Management Inc.16,455$236K0.0%-10.8%0.125% 8/1/2024Rhumbline Advisers6,799$117K0.0%N/A0.053% 7/26/2024 Bank of New York Mellon Corp15,295$264K0.0%N/A0.119% 5/10/2024Vanguard Group Inc.223,102$4.45M0.0%+0.6%1.732% 2/14/2023683 Capital Management LLC11,700$178K0.0%N/A0.091% 11/15/2022Pura Vida Investments LLC19,667$179K0.0%N/A0.153% 8/8/2022Walleye Capital LLC10,656$90K0.0%N/A0.082% 4/29/2022 Nisa Investment Advisors LLC7,200$141K0.0%N/A0.056% 2/7/2022 SG Americas Securities LLC4,395$107K0.0%N/A0.034% 11/15/2021Invesco Ltd.148,087$5.79M0.0%-47.1%1.138% 11/15/2021Tibra Equities Europe Ltd12,700$496K0.8%N/A0.098% 11/12/2021OLD Mission Capital LLC7,358$287K0.0%N/A0.057% 11/12/2021 Geode Capital Management LLC56,919$2.22M0.0%+8.6%0.437% 8/17/2021Invesco Ltd.280,062$12.59M0.0%N/A2.171% 8/16/2021California State Teachers Retirement System5,588$251K0.0%N/A0.043% 8/16/2021Charles Schwab Investment Management Inc.9,819$442K0.0%N/A0.076% 8/16/2021State Street Corp50,212$2.26M0.0%N/A0.389% 8/16/2021Nuveen Asset Management LLC6,392$287K0.0%N/A0.050% 8/13/2021Northern Trust Corp12,098$544K0.0%N/A0.094% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here8/13/2021 Geode Capital Management LLC52,395$2.35M0.0%+262.3%0.406% 8/13/2021Vanguard Group Inc.121,418$5.46M0.0%+14.3%0.941% 8/12/2021State of Wisconsin Investment Board5,200$234K0.0%N/A0.040% 8/12/2021JPMorgan Chase & Co.4,789$216K0.0%N/A0.037% 8/11/2021 Bank of New York Mellon Corp6,664$300K0.0%N/A0.052% 8/11/2021BlackRock Inc.217,748$9.79M0.0%+242.7%1.688% 8/11/2021Deutsche Bank AG2,396$108K0.0%N/A0.019% 8/10/2021Citigroup Inc.1,611$72K0.0%+212.8%0.012% 8/2/2021New York State Common Retirement Fund3,500$157K0.0%N/A0.027% 5/18/2021Millennium Management LLC19,450$663K0.0%+169.7%0.000% 5/17/2021Royal Bank of Canada2,800$95K0.0%N/A0.000% (Data available from 1/1/2016 forward) GLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLSI shares? During the previous two years, 18 institutional investors and hedge funds held shares of Greenwich LifeSciences. The most heavily invested institutionals were Vanguard Group Inc. ($4.45M), Geode Capital Management LLC ($1.26M), State Street Corp ($1.03M), Northern Trust Corp ($982K), Bank of New York Mellon Corp ($264K), Renaissance Technologies LLC ($255K), and Garden State Investment Advisory Services LLC ($253K).Learn more on Greenwich LifeSciences' institutional investors. What percentage of Greenwich LifeSciences' stock is owned by institutional investors? 4.16% of Greenwich LifeSciences' stock is owned by institutional investors. Learn more on GLSI's institutional investor holdings. Which institutional investors have been buying Greenwich LifeSciences' stock? Of the 17 institutional investors that purchased Greenwich LifeSciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Garden State Investment Advisory Services LLC ($35.20K), Strs Ohio ($18.60K), HighTower Advisors LLC ($15.41K), Bank of New York Mellon Corp ($15.30K), Barclays PLC ($14.16K), Rhumbline Advisers ($13.14K), and Northern Trust Corp ($12.92K). How much institutional buying is happening at Greenwich LifeSciences? Institutional investors have bought a total of 130,785 shares in the last 24 months. This purchase volume represents approximately $1.56M in transactions. Which of Greenwich LifeSciences' major shareholders have been selling company stock? The following institutional investors have sold Greenwich LifeSciences stock in the last 24 months: Renaissance Technologies LLC ($9.80K), and Charles Schwab Investment Management Inc. ($2.00K). How much institutional selling is happening at Greenwich LifeSciences? Institutional investors have sold a total of 11,799 shares in the last 24 months. This volume of shares sold represents approximately $138.78K in transactions. Related Companies REPL Institutional Ownership EOLS Institutional Ownership PHAT Institutional Ownership KROS Institutional Ownership RLAY Institutional Ownership BCAX Institutional Ownership TLRY Institutional Ownership ORGO Institutional Ownership XNCR Institutional Ownership MRVI Institutional Ownership This page (NASDAQ:GLSI) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access